Evidence That the Clinical Impairment Assessment (CIA) Subscales Should Not Be Scored: Bifactor Modelling, Reliability, and Validity in Clinical and Community Samples by Raykos, B. et al.
CLINICAL IMPAIRMENT ASSESSMENT  1   
 
 
 
 
 
 
 
 
 
Evidence that the Clinical Impairment Assessment (CIA) subscales should not be 
scored: Bifactor modelling, reliability, and validity in clinical and community samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Running Head: CLINICAL IMPARIMENT ASSESSMENT
CLINICAL IMPAIRMENT ASSESSMENT  2   
 
Abstract 
Aim: The Clinical Impairment Assessment (CIA 3.0; Bohn et al., 2008) is the most 
widely used instrument assessing psychosocial impairment secondary to eating disorder 
symptoms.  However, there is conflicting advice regarding the dimensionality and optimal 
method of scoring the CIA.  We sought to resolve this confusion by conducting a 
comprehensive factor analytic study of the CIA in in a community sample (N = 301) and 
clinical sample comprising patients with a diagnosed eating disorder (N = 209).  Convergent 
and discriminant validity were also assessed.  Method: The CIA and measures of eating 
disorder symptoms were administered to both samples.  Results: Factor analyses indicated 
there is a general impairment factor underlying all items on the CIA that is reliably measured 
by the CIA Global score.  CIA Global demonstrated good convergent and discriminant 
validity.  Conclusions: CIA Global is a reliable and valid measure of psychosocial 
impairment secondary to eating disorder symptoms however subscale scores should not be 
computed.  
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Evidence that the Clinical Impairment Assessment (CIA) subscales should not be scored: 
Bifactor modelling, reliability, and validity in clinical and community samples 
 The Clinical Impairment Assessment (CIA v. 3.0; Bohn et al., 2008) is the most 
widely used instrument assessing psychosocial impairment secondary to eating disorder 
cognitions and behaviours.  The instrument asks respondents to rate the extent to which their 
eating habits, exercising, or feelings about eating, shape or weight have resulted in particular 
psychosocial consequences (e.g., “made you feel ashamed of yourself”) over the past 28 
days.  Measuring impairment is important given that the presence of clinically significant 
impairment secondary to eating disorder symptoms is required to diagnose an eating disorder 
(Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition; DSM-5; American 
Psychiatric Association (APA), 2013).   
The CIA is appealing to researchers and clinicians due to its ability to capture 
impairment resulting directly from symptoms of the eating disorder.  As such, it is frequently 
used in randomised controlled trials (e.g. Fairburn et al., 2015) and effectiveness studies (e.g., 
Turner, Marshall, Stopa, & Waller, 2015) as a key outcome variable assessing the degree to 
which psychosocial impairment reduces over treatment.  The CIA has also been used in 
diverse community samples, including university students, adult men and women, 
adolescents, and women at-risk of developing an eating disorder.  Norms for the CIA have 
now been established for the United Kingdom (Bohn et al., 2008; Jenkins, 2013) and the 
United States (Vannucci et al., 2012), and norms for translated versions of the instrument 
have been established for Norway (Reas et al., 2010; Ro, Bang, Reas, & Rosenvinge, 2012), 
Sweden (Welch et al., 2011), and Fiji (Becker et al., 2010), highlighting the wide appeal of 
the instrument cross-culturally.  Therefore, it is important to establish that the psychometric 
properties of the CIA are sound and replicable.   
CIA Dimensionality and Scoring 
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Despite wide use of the CIA, there is conflicting advice over what aspects of 
impairment the CIA measures, and how it should be scored.  Bohn et al. (2008, p. 1105) 
stated that the CIA is designed to measure “impairment overall and in three specific domains 
(personal, cognitive, social).”  Examples of items tapping the three domains are “made you 
feel like a failure” (personal impairment), “stopped you going out with others” (social 
impairment), and “made you forgetful” (cognitive impairment).  Bohn et al. computed 
subscale scores for the three domains, and also averaged all items to form a global score.  In 
contrast, Bohn and Fairburn (2008a) noted that “The purpose of the CIA is to provide a 
simple single index … to measure the overall severity of secondary psychosocial 
impairment” (p. 315-16, emphasis in original) and made no mention of subscale scores.  In 
subsequent research, a variety of approaches have been used, such as describing and 
reporting the three domain scores only (e.g., Martin et al., 2015), describing the three 
domains but reporting only the global score (e.g., Hogdahl, Levallius, Bjorck, Norring, & 
Birgegard; 2016), and describing and reporting only the global score (e.g., DeJong et al., 
2013).  The inconsistency in how the CIA is scored appears to stem from a lack of clarity as 
to whether the instrument measures several distinct forms of impairment, or whether all items 
in the scale are indicators of one common underlying mechanism. 
Factor analysis can help clarify how many forms of impairment the CIA measures, 
and provide guidance on how it should be scored.  To date, six factor analytic studies 
investigating the CIA have been conducted (Bohn et al., 2008; Jenkins, 2013; Parker, 
Mitchell, O’Brien, & Brennan, 2015; 2016; Martin et al., 2015; Reas et al., 2010; Vannucci et 
al., 2012).  A strength of confirmatory factor analysis (CFA) is that the statistical fit of 
several factor models can be compared in order to determine the optimal model.  However, 
this feature of CFA has not been utilised in studies to date.  Only a three-factor model has 
been considered and found to have adequate fit (e.g., Jenkins, 2013), leading the authors to 
CLINICAL IMPAIRMENT ASSESSMENT  5   
 
conclude that three factors underlie the CIA.  This conclusion may be premature, given the 
three-factor model has not been shown to be better than alternatives such as a single-factor 
(unidimensional) model. 
Another limitation of studies that have modelled CIA responses using three factors is 
that the size of the inter-factor correlations has never been reported.  The magnitude of the 
inter-factor correlations has important implications for how the CIA should be scored.  Weak 
correlations would imply that computing subscales is sound (as each would measure a 
distinct aspect of impairment), and also that calculating a global CIA score is unjustified (as it 
would involve combining items that measure three unrelated constructs).  In contrast, large 
correlations would suggest the constructs being measured by each subscale overlap greatly, 
and that it would be most parsimonious to calculate only a global score. 
While some authors have concluded the CIA measures three distinct factors (e.g., 
Jenkins, 2013; Reas et al., 2010), other evidence indicates the CIA may measure a single, 
general impairment factor.  For example, a ratio of the first to second eigenvalues greater 
than 4:1 is often regarded as evidence that an instrument primarily measures a single 
construct (Reeve et al., 2007).  Bohn et al. (2008) conducted a Principal Components 
Analysis and reported that the first two eigenvalues were 9.52 and 1.12, which is a ratio of 
8.5:1.  Furthermore, Bohn et al. modelled the CIA using a unidimensional Item Response 
Theory model and found that it provide a good fit to that data. 
At first glance it seems contradictory that all CIA items load on a single impairment 
factor, yet analyses using a three-factor model also demonstrate adequate fit.  However, such 
findings would be expected if the CIA has a bifactor structure.  A bifactor model comprises a 
general factor that influences responses to every item, and group factors that influence 
responses to subsets of items (see Figure 1).  Bifactor models have been found to provide an 
CLINICAL IMPAIRMENT ASSESSMENT  6   
 
excellent fit to many psychological instruments (Rodriguez, Reise, & Haviland, 2016a).  To 
date, no factor analyses of the CIA have used bifactor models. 
The CIA is a good candidate for bifactor modelling.  Every item in the scale is 
designed to measure clinical impairment – thus there should be a general impairment factor 
on which every item loads.  However the general impairment factor alone may not adequately 
model CIA responses due to the existence of item clusters that tap personal, social, and 
cognitive impairments.  Items within each cluster should be more strongly correlated with 
each other than they are with items from other clusters.  Modelling CIA responses using the 
general impairment factor and additional cognitive, social, and personal group factors may 
better account for associations between the items than using the general factor alone, or using 
only the three group factors. 
An appealing feature of applying a bifactor model to the CIA is that the relative 
importance of the general and group factors can be quantified and used to determine whether 
global and/or subscale scores should be computed (Reise, Bonifay & Haviland, 2012).  If the 
group factors explain little variance in CIA scores it would indicate that only a global score 
should be computed, whereas if they exert a strong influence on participants’ responses it 
would suggest subscales should be computed. Several statistical indices can be calculated for 
bifactor models to determine whether global or subscale scores should be computed (Reise, 
Moore, & Haviland, 2010; Rodriguez, Reise, & Haviland, 2016a,b). 
Aims of the Current Study 
In the present study we sought to resolve confusion about the dimensionality and 
optimal method of scoring the CIA by conducting a comprehensive factor analytic study of 
the CIA in two samples – one clinical, and one community.  We were particularly interested 
in determining whether subscale scores should be computed in addition to, or instead of, a 
global score.  We also assessed the convergent and discriminant validity of the CIA.  We 
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hypothesised that: 1) a bifactor model with a strong general factor would provide a better fit 
to the data than unidimensional or three-factor models; 2) CIA scores would be significantly 
positively correlated with scores on measures of eating disorder psychopathology in both 
samples; and 3) patients with a diagnosed eating disorder would have significantly higher 
CIA scores than individuals in the community. 
Method 
Participants and Procedures 
Community and clinical samples were collected.  The community sample consisted of 
university students while the clinical sample was recruited from a specialist eating disorders 
service and met diagnostic criteria for an eating disorder.  Demographic characteristics are 
presented in Table 1. 
Community sample.   
Participants (N = 301) were university students who ranged in age from 17-54 years, 
with a mean age of 21.3 years (SD = 5.3 years), who were recruited via online advertisements 
placed on university websites. Participants first read an information sheet in which they were 
informed of the confidential nature of their responses and their right to withdraw without 
prejudice. After indicating consent, participants completed the online survey and received 
course credit in exchange for their participation.  This study received approval from the 
Institution’s Human Research Ethics Committee (Approval Number HR161/2014). 
Clinical sample.   
Participants (N = 209) were individuals with a diagnosed eating disorder (DSM-5; 
APA, 2013) who completed the CIA as part of their assessment at a specialist public mental 
health service with a dedicated eating disorders programme.  Individuals with binge eating 
disorder (BED) are not treated at the clinic and are referred elsewhere.  Individuals ranged in 
age from 16 to 73 years, with a mean age of 25.3 years (SD = 8.6 years).  The clinical group 
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was recruited via two pathways.  Some patients (n = 98) completed the CIA at assessment as 
part of routine clinical practice, comprising individuals with principal DSM-5 diagnoses of 
AN (16%), BN (54%), and OSFED (30%).  This study received approval from the 
Institution’s Human Research Ethics Committee (Approval Number QI 2014/21).  The 
remaining patients (n = 111) completed the CIA at assessment as part of an anorexia nervosa 
(AN) randomised controlled trial (RCT), and all met DSM-5 criteria for AN.  This study 
received ethics approval from multiple institutions (see Andony et al., 2014).  Exclusion 
criteria across both clinical recruitment pathways included current psychosis, schizophrenia, 
or schizoaffective disorder, significant alcohol or substance abuse/dependence, and a BMI 
below 14 kg/m2.  Only patients who provided written informed consent for their data to be 
used were included. 
Measures 
The Clinical Impairment Assessment 3.0 (CIA; Bohn & Fairburn, 2008a).  The CIA is 
a 16-item self-report measure that assesses impairment experienced over the past 28 days 
secondary to eating disorder symptoms.  Each item is rated on a 4-point Likert scale ranging 
from 0 (“not at all”) to 3 (“a lot”), with CIA Global scores ranging from 0-48.   
Eating Disorder Examination interview (EDE Version 12; Fairburn & Cooper, 1993).  
Clinicians administered the EDE to all clinical patients to assist in yielding a reliable eating 
disorder diagnosis.  Clinicians were Clinical Psychologists trained in administration of the 
EDE and specializing in eating disorder treatment.  The EDE Total score assessed the CIA’s 
convergent validity in the clinical sample. The EDE has good convergent and concurrent 
validity, good inter-rater reliability, and discriminates well between groups with and without 
an eating disorder (Berg, Peterson, Frazier, & Crow, 2012; Fairburn & Cooper, 1993). 
The Eating Disorder Examination-Questionnaire Version 5 (EDE-Q; Fairburn & 
Beglin, 1994).  The EDE-Q was administered to all individuals in the community sample and 
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to clinical patients recruited via the community mental health clinic (n = 98).  The EDE-Q is 
a self-report measure of eating disorder psychopathology that assesses symptoms experienced 
over the past 28 days.  The EDE-Q was administered prior to the administration of the CIA, 
as recommended by Bohn and Fairburn (2008b), to ensure that eating disorder features are at 
the forefront of the respondents mind.  The EDE-Q Global score assessed the CIA’s 
convergent validity in the community and clinical samples.  EDE-Q Global ranges from 0 to 
6, with higher scores indicating more severe psychopathology.  EDE-Q Global has acceptable 
reliability and validity (Berg, Peterson, Frazier, & Crow, 2012).  Internal consistency of 
EDE-Q Global was high in the clinical (α = .87) and community (α = .92) samples. 
Body Mass Index (BMI).  In the community sample, BMI was computed based on 
self-reported height and weight collected using the EDE-Q.  In the clinical sample, a clinician 
measured patients’ height at assessment and weighed individuals (clothed but without shoes 
or outer garments) to calculate objective BMI. 
Data Analysis 
 We conducted a series of analyses to evaluate the dimensionality of the CIA, using 
factor analytic techniques recommended in recent psychometric literature (Flora, LaBrish, & 
Chalmers. 2012; Rhemtulla, Brosseau-Lairrd & Savalei, 2012; Rodriguez, Reise, & Haviland, 
2016a,b).  We evaluated the statistical fit of four CFA models (see Figure 1) that were 
selected based on theory and findings of prior factor analyses of the CIA.  These models 
were: a unidimensional model; uncorrelated and correlated three-factor models, and a bifactor 
model in which the three group factors corresponded to the Personal, Social, and Cognitive 
factors proposed by Bohn et al. (2008). Including correlated and uncorrelated three-factor 
models was important because prior researchers have not specified whether they allowed the 
factors to covary, and these two models have distinctly different implications for how the 
CIA should be scored.  The CFAs were conducted using the R package ‘lavaan’ (Rosseel, 
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2012) using the WLSMV estimator. Models were identified by fixing factor variances to 1.  
Statistical fit was examined using the Comparative Fit Index (CFI ≥.95 indicative of good 
fit), Tucker-Lewis Index (TLI ≥.95 indicative of good fit), Root Mean Square Error of 
Approximation (RMSEA ≤.06 indicative of good fit) and Standardized Root Mean Residuals 
(SRMR ≤.08 indicative of good fit, Hu & Bentler, 1999)1. Differences in fit between nested 
models were tested using scaled Chi-Square difference tests.2  Judgements about which factor 
model to retain were based on multiple criteria (global fit statistics, difference tests, local fit 
diagnostics, bifactor indices, and theoretical reasoning), as recommended by Schmitt (2011).  
Analyses were conducted separately for clinical and community samples.   
For the bifactor model, we computed several indices recommended by Rodriguez, 
Reise, and Haviland (2016a,b).  Omega hierarchical is a reliability coefficient that measures 
the proportion of variance in CIA global scores that is attributable to each common factor in a 
bifactor model.  Omega total is proportion of variance in CIA global scores accounted for 
collectively by all of the factors.  Omega subscale and Omega subscale hierarchical 
reliability coefficients were also computed for subscales.  When Omega hierarchical is high 
(e.g., > .80), composite scores can be considered essentially unidimensional, because the vast 
majority of variation in scores is due to a single source (Rodriguez et al., 2016a).   
The extent to which it is feasible to model bifactor data using a simple unidimensional 
model in SEM can be assessed through two indices – the Explained Common Variance 
(ECV) and the Proportion of Uncontaminated Correlations (PUC).  ECV is the variance 
explained by the general factor, divided by the variance explained by the general and group 
factors.  It provides an indication of ‘how unidimensional’ an instrument is.  PUC is the 
number of correlations between items from different group factors, divided by the total 
number of correlations between items in the factor model.  When ECV and PUC both exceed 
> .70, any bias in parameter estimates caused by ignoring the group factors will be minimal 
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(Rodriguez, 2016a).  Another way of assessing the potential bias in parameter estimates from 
using a unidimensional rather than full bifactor model is to calculate the mean relative bias of 
the factor loadings.  This involves comparing the loadings on the general factor in a bifactor 
model, against those from a unidimensional model.  For example, imagine the standardized 
loading for an item was .80 on the general factor in the bifactor model, and .82 in the 
unidimensional model. The difference between the loadings (known as the relative bias) is 
.02 – a negligible amount.  The mean relative bias is the average (absolute) difference in 
loadings for all items in a scale.  Finally, Coefficient H is a reliability index that provides 
information about how well each latent variable in a bifactor model is measured by its 
indicators.  Factors with H values below .70 are poorly defined by their indicators, and of 
questionable utility (Rodriguez, 2016b). 
Other analyses were conducted with SPSS v. 18.0 (SPSS Inc., Chicago, Illinois).  
Pearson correlations between CIA Global and eating disorder psychopathology (EDE-Q 
Global and EDE Total) assessed the CIA’s convergent validity.  Independent samples t-tests 
were performed to compare CIA Global between community and clinical samples.  Cohen’s d 
effect sizes were computed using the online calculator at https://www.uccs.edu/~lbecker/. 
Results 
Confirmatory Factor Models  
Robust fit statistics are presented in Table 2. The unidimensional model had 
acceptable CFI and TLI values, but the RMSEA and SRMR exceeded guidelines for good 
fitting models.  The fit of the three uncorrelated factor model was extremely poor in both 
community and clinical samples, with low CFI and TLI values and very high RMSEA and 
SRMR values. The correlated three-factor model produced good fit statistics, except for the 
RMSEA.  Factor intercorrelations were very high in both the community (r = .87, .86, and 
.71) and clinical samples (r = .78, .78, .74), suggesting an unmodelled general factor is 
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responsible for the high inter-correlations.  The fit of the bifactor model was excellent in both 
samples.  Scaled chi-square difference tests indicated that the observed data fit the bifactor 
model statistically significantly better (p < .001) than the unidimensional model and the three 
uncorrelated factor model, and that the fit of the bifactor and correlated traits model was not 
significantly different (clinical sample p = .25, community sample p = .46). 
Bifactor Indices 
 Bifactor indices are presented in Table 3. The Explained Common Variance (ECV) 
values demonstrate that the general factor accounted for more than 90% of the explained 
common variance in both samples.  This indicates that the CIA primarily measures a single, 
general impairment factor, despite technically being a multidimensional instrument. Omega 
reliability coefficients for the CIA global score and each subscale were very high (> .90).  
Omega-hierarchical values (.91 community, .88 clinical) were also high, whereas all Omega-
subscale values were very low (< .06).  These findings indicate that CIA Global is a reliable 
measure of the general impairment factor, but that the subscales are unreliable measures of 
the group factors. 
Factor Loadings 
 Standardized factor loadings for the bifactor model are presented in Table 4.  All 
items had high loadings on the general factor.  As a comparison, loadings for the 
unidimensional solution are also presented.  The discrepancy between these loadings is 
measured by the mean relative bias statistic, which was low (.07) for both samples, providing 
further evidence that the CIA primarily measures a general impairment factor. 
Associations between CIA and eating disorder psychopathology 
As predicted, positive correlations were observed between CIA Global and EDE-Q 
Global in both the community (r = .86, p < .001) and clinical (r = .67, p < .001) samples.   
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Positive correlations were also observed between CIA Global and EDE Total in the clinical 
sample (r = .54, p < .001).  
Comparisons between clinical and community samples 
Patients with a diagnosed eating disorder had significantly higher CIA Global (M = 
34.0, SD = 10.6) than individuals in the community (M = 11.0, SD = 10.4), d = 2.2, t(508) = 
24.27, p < .001, and also demonstrated significantly higher EDE-Q Global and EDE Total 
scores (see Table 5). 
Discussion 
The present study sought to resolve confusion about the dimensionality and optimal 
method of scoring the CIA, and to assess the convergent and discriminant validity of the CIA 
in clinical and community samples.  As predicted by hypothesis one, a bifactor model with a 
strong general factor provided a better fit to the data than viable alternative models.  The 
present findings indicate that the CIA is technically multidimensional, but that it primarily 
measures a strong general impairment factor.  This has several implications.  First, CIA 
Global scores are a reliable measure of the overall severity of impairment due to eating 
disorder features, and should be routinely reported.  Second, subscales should not be scored 
as they primarily measure the general factor rather than specific cognitive, personal, or social 
impairments.  Third, because the general factor is strong and the group factors are weak, it is 
acceptable for researchers using the CIA in SEM analyses to ignore the group factors and 
model the CIA using a single factor (Reise, Scheines, Widaman, & Haviland, 2013).  This is 
simpler than fitting a bifactor model, and should not substantively affect the results of SEM 
analyses. Future research could (i) assess the possibility that a shorter version of the CIA 
could reliably measure clinical impairment secondary to eating disorder symptoms, and (ii) 
test the factorial invariance of solutions obtained from different populations.3 
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As predicted by hypothesis 2, and consistent with previous research, convergent 
validity of the CIA was supported, as CIA Global exhibited moderate to strong positive 
associations with eating disorder severity (EDE-Q Global and EDE Total) in the community 
and clinical samples.  As predicted by hypothesis 3, and consistent with previous research, 
CIA Global discriminated well between clinical and community samples.  Notably, the mean 
CIA Global score for the community sample (M = 11.0) was higher than reported in previous 
community studies, including a sample of high-risk females (M = 8.3; Vannucci et al., 2012).  
This discrepancy may reflect the high proportion of individuals in the present community 
sample who endorsed having had a diagnosed eating disorder (3.2%) or who believed they 
may have had an undiagnosed eating disorder (14.4%).  The proportion of individuals in the 
present sample community endorsing eating disorder symptoms is consistent with Jenkins 
(2013), who found that 14.8% of their university sample had spoken to a health professional 
about eating, shape, or weight concerns.  It is also consistent with wider literature 
demonstrating high prevalence of eating disorders amongst university students, with 20% to 
34% of individuals self-reporting an eating disorder diagnosis (e.g. National Eating Disorders 
Association, 2006; White, Reynolds-Malear, & Cordero, 2011).  The mean CIA Global in the 
present clinical sample was equivalent to the highest mean reported in the literature (Welch et 
al., 2011), suggesting that individuals were highly impaired by their symptoms when they 
presented for treatment.  The community clinic in this study is the only public outpatient 
service specialising in treatment of eating disorders in the state and, due to long waitlists, 
treatment may not be available for several months.  Further research is needed to determine 
whether similar levels of clinical impairment are evident in individuals who seek treatment in 
other settings, such as inpatient or private practice settings where treatment may be accessed 
more promptly. 
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The present study has several strengths.  It is the first time several factor models have 
been compared using CFA and the first study to use bifactor modelling.  Findings from our 
clinical sample were replicated in a community sample.  This is important, as the CIA is 
frequently used with non-clinical samples, despite originally being designed for use with 
clinical populations.  Our clinical sample was larger and had a higher proportion of 
individuals diagnosed with Anorexia Nervosa than previous studies (e.g., Bohn et al, 2008).  
Furthermore, all individuals in the clinical sample were diagnosed with eating disorders, 
whereas some previous studies have included subthreshold cases (e.g., Vannucci et al., 2012), 
or focused on individuals with obesity (Parker et al., 2016). 
The current study has notable limitations.  The community sample comprised adult 
university students therefore results may not generalise to other community samples.  The 
clinical sample did not include individuals with BED or individuals younger than 16 years of 
age.  Further research is needed to examine the factor structure, reliability, and validity of the 
CIA in patients with BED and younger patients with eating disorders to determine the 
replicability of the present findings.  The present study did not include an objective measure 
of impairment, although previous research has demonstrated strong positive correlations 
between CIA Global and clinician-rated impairment (Bohn et al., 2008).  Bifactor models 
also have limitations, such as a tendency to overfit data (Binfay, Lane, & Reise, 2017).  For 
this reason it is important to consider alternative lines of evidence, such as bifactor indices, 
when evaluating the fit of a bifactor model – as was done in this study.  Another limitation of 
bifactor models is and that the emergence of a strong general impairment factor does not 
necessarily imply there is a single latent mechanism that causes impairment in people with 
eating disorders.  A strong general factor may just indicate that the observable signs of 
impairment – as measured by CIA items – are so highly correlated that it is not possible (or 
necessary) to subdivide them into smaller, discrete categories (Bonifay et al , 2017). It is also 
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important to acknowledge that there may also be additional aspects of impairment not 
assessed by the CIA that are more separable from the common factor. Bifactor analysis can 
only speak to the structure of the particular measure under study, not to the underlying 
construct. 
In sum, the present paper offers clear guidelines for scoring and interpretation of the 
CIA.  We recommend that CIA Global is routinely reported in future studies as a valid and 
reliable measure of clinical impairment secondary to eating disorder symptoms.  However, 
CIA subscale scores should not be computed.   
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Footnotes 
1 We acknowledge that these ‘rules of thumb’, while commonly used, have important 
limitations and should not be the sole way in which model fit is assessed (see Kline, 2015). 
2 This is equivalent to using DIFFTEST in Mplus. 
3 We attempted to conduct analyses testing measurement invariance for the bifactor model, 
but the metric and scalar invariance models would not converge.  This is likely due to an 
interaction between the complexity of the bifactor model, and relatively small size of the 
clinical sample.  Future studies examining measurement invariance are likely to require 
considerably larger samples than were employed in the current study.  
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Table 1 
Characteristics of the Clinical (N = 209) and Community (N = 301) Samples. 
Baseline Variable Clinical sample Non-clinical sample 
Age (years)                         
M (SD), range 
 
25.3 (8.6), 16-73 
 
21.3 (5.3), 17-54 
Gender, n 
Female: Male: Other 
 
203:6:0 
 
248:51:2 
Body mass index1 
M (SD), range 
 
18.8 (3.6), 13.8-37.0 
 
23.0 (4.7), 15.6-39.1 
Employment status, n (%) 
Full/part-time                                   
Unemployed 
Missing 
 
135 (64.6%) 
65 (31.1%) 
9 (4.3%) 
 
233 (77.4%) 
68 (22.6%) 
- 
Ethnicity, n (%) 
Aust-Anglo/Europ 
Aust-Asian 
Other 
Missing 
 
193 (92.3%) 
1 (0.5%) 
14 (6.7%) 
1 (0.5%) 
 
225 (75%) 
37 (12.3%) 
39 (13%) 
- 
Education, n (%) 
       Less than year 12 
       Year 12 or equivalent 
       Technical/trade 
       Tertiary 
       Missing 
 
24 (11.4%) 
75 (35.9%) 
26 (12.4%) 
61 (29.2%) 
 23 (11.0%)  
 
- 
- 
- 
301 (100%) 
- 
Relationship status, n (%) 
       Single 
        Defacto/Married        
        Divorced/separated 
Missing 
 
140 (67.0%) 
53 (25.4%) 
8 (3.8%) 
8 (3.8%) 
 
256 (84.2%) 
44 (14.6%) 
1 (0.3%) 
- 
ED Diagnosis, n (%) 
        AN 
        BN 
OSFED 
Believe I have had an ED, 
never diagnosed 
 
127 (60.8%) 
53 (25.4%) 
29 (13.9) 
- 
 
 1 (0.3%)  
8 (2.6%) 
1 (0.3%) 
45 (14.5%) 
ED Chronicity (years) 
M (SD), range 
 
6.6 (6.7), 0.25-28 
 
N/A 
Note: ED =  Eating Disorder; M = Mean; SD = Standard Deviation;  
1BMI for community sample was computed from self-reported height and weight. 
2ED diagnosis for community sample is based on self-report diagnosis from a health 
professional  
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Table 2. 
Robust Fit Statistics for Confirmatory Factor Analysis Models 
                90% CI     
Model X df   CFI TLI   RMSEA LL UL   SRMR 
Community Sample 
           Unidimensional 615.8 104 
 
.966 .961 
 
.128 .118 .138 
 
.105 
Three Independent Factors 5800.0 104 
 
.625 .567 
 
.427 .418 .437 
 
.508 
Three Correlated Factors 220.2 101 
 
.992 .991 
 
.063 .051 .074 
 
.044 
Bifactor 147.0 88 
 
.996 .995 
 
.047 .033 .060 
 
.034 
            Clinical Sample 
           Unidimensional 504.2 104 
 
.912 .898 
 
.136 .124 .148 
 
.095 
Three Independent Factors 2426.6 104 
 
.488 .409 
 
.328 .316 .339 
 
.417 
Three Correlated Factors 230.4 101 
 
.971 .966 
 
.078 .065 .092 
 
.057 
Bifactor 135.5 88 
 
.990 .986 
 
.051 .033 .067 
 
.041 
            Good Fit Guidelines       >.95 >.95   <.06       <.08 
 
Note.  CFI = Comparative Fit Index; TLI = Tucker-Lewis Index; RMSEA = Root Mean 
Square Error of Approximation; SRMR = Standardized Root Mean Residuals (SRMR). LL 
and UL = Lower and Upper Limits of 90% Confidence Interval.  Guidelines for good fitting 
models are from Hu & Bentler (1999). P values for all Chi-Square tests were < .001 except 
for the Bifactor model in the Clinical Sample where p = .001. 
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Table 3. 
Bifactor Indices 
  Community   Clinical 
Index Gen GR-P GR-S GR-C   Gen GR-P GR-S GR-C 
Omega .98 .97 .96 .95 
 
.97 .94 .93 .91 
Omega H / Omega HS .91 .05 < .01 .03 
 
.88 .05 .01 .02 
ECV .92 
    
.91 
   PUC .71 
    
.71 
   Mean relative bias .07 
    
.07 
   H .97 .66 .26 .62   .95 .67 .55 .61 
Omega = Omega total / Omega subscale. Omega H/S = Omega Hierarchical (for general factor) and Omega hierarchical subscale (for group 
factors). ECV = Explained Common Variance. Percentage of uncontaminated correlations (PUC).  H = Coefficient H Construct Reliability. Gen 
= General Factor. GR-P, GR-S, GR-C = Group Personal, Social and Cognitive Factors.  
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Table 4 
Standardized Factor Loadings for Unidimensional and Bifactor Restricted (Confirmatory) Factor Solutions 
  
Community Sample 
 
Clinical Sample 
  
Uni 
 
Bifactor 
 
Uni 
 
Bifactor 
Item 
 
  Gen GR-P GR-S GR-C   
 
  GEN GR-P GR-S GR-C 
1 ….made it difficult to concentrate? .83 
 
.84 
  
.30 
 
.76 
 
.78 
  
.19 
2 ….made you more critical of yourself? .90 
 
.79 .47 
   
.74 
 
.71 .30 
  3 ….stopped you going out with others? .80 
 
.85 
 
-.06 
  
.78 
 
.79 
 
.20 
 4 ….affected your performance at work (if applicable)? .71 
 
.62 
  
.53 
 
.67 
 
.65 
  
.28 
5 ….made you forgetful? .81 
 
.69 
  
.63 
 
.78 
 
.63 
  
.70 
6 ….affected your ability to make everyday decisions? .81 
 
.76 
  
.45 
 
.73 
 
.71 
  
.30 
7 ….interfered with meals with family or friends? .80 
 
.82 
 
.37 
  
.76 
 
.71 
 
.44 
 8 ….made you upset? .94 
 
.80 .52 
   
.81 
 
.71 .48 
  9 ….made you feel ashamed about yourself? .94 
 
.81 .49 
   
.82 
 
.63 .71 
  10 ….made it difficult to eat out with others? .83 
 
.86 
 
.34 
  
.76 
 
.69 
 
.70 
 11 ….made you feel guilty? .87 
 
.74 .50 
   
.87 
 
.82 .38 
  12 ….interfered with your doing things you used to enjoy? .84 
 
.92 
 
-.22 
  
.78 
 
.80 
 
.16 
 13 ….made you absent-minded? .85 
 
.79 
  
.45 
 
.82 
 
.73 
  
.54 
14 ….made you feel a failure? .91 
 
.83 .41 
   
.82 
 
.74 .42 
  15 ….interfered with your relationship with others? .89 
 
.94 
 
.03 
  
.78 
 
.82 
 
.06 
 16 ….made you worry? .88   .73 .54       .77   .70 .40     
Note. Uni = Unidimensional model loading.  GEN = General Factor in Bifactor solution. GR-P = Group Personal Factor. GR-S = Group Social 
Factor. GR-C = Group Cognitive Factor 
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Table 5 
Descriptives and Comparison of Community (N = 301) and Clinical (N = 209) Samples on 
CIA Global, EDE-Q Global, and EDE Total. 
Baseline Variable Clinical sample 
M (SD), range 
Community 
sample 
M (SD), range 
t-value  p-value d 
CIA Global 34.0 (10.6), 1-48 11.0 (10.4), 0-45 24.28 < .001 2.19 
EDE-Q Global 4.3 (1.2), 0.5-5.7 1.9 (1.4), 0-5.8 16.77 < .001 1.84 
EDE Total 3.3 (1.4), 0.1-5.6 - - -  
Note: Only patients from the community clinic completed the EDE-Q (n = 98)  
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Figure 1 
Restricted (Confirmatory) Factor Models 
 
 
 
